米国企業
LIGAND PHARMACEUTICALS INC

LIGAND PHARMACEUTICALS INCLGND

時価総額

$18.3億

PER

35倍

	2011年 12月31日	2012年 12月31日	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日
Cash and cash equivalents	7	12	12	160	97	19	21	117	72	48	20	45	23
Short-term investments	10	-	4	7	103	122	181	601	940	364	322	167	147
Accounts receivable, net	-	-	-	-	-	-	-	-	30	57	85	30	33
Inventory	1	2	1	0	2	2	4	7	7	26	27	13	24
Income taxes receivable	-	-	-	-	-	-	-	-	11	2	6	5	6
Other current assets	1	1	1	2	2	2	2	20	5	4	5	3	3
Prepaid expenses	-	-	-	-	-	-	-	-	-	-	-	-	1
Other current assets	1	1	1	2	2	2	2	20	5	4	5	3	3
Total current assets	32	24	25	185	216	163	237	871	1,124	501	465	264	237
Deferred income taxes, net	-	-	-	-	-	-	84	47	26	24	34	9	0
Intangible assets, net	57	56	53	51	48	205	229	220	210	595	551	342	300
Goodwill	15	12	12	12	12	72	86	87	95	190	181	106	103
Commercial License Rights	-	-	5	5	9	26	20	31	20	11	10	10	67
Property and equipment, net	0	1	1	0	0	2	4	5	7	14	21	12	16
Operating lease assets	-	-	-	-	-	-	-	-	10	7	17	11	6
Finance lease assets	-	-	-	-	-	-	-	-	-	16	16	4	3
Other assets	1	1	0	0	0	2	5	0	2	4	3	5	6
Equity Method Investments	-	-	-	-	30	8	6	-	-	-	-	-	13
Other investments	-	-	-	-	-	-	-	-	-	-	-	-	36
Total assets	122	104	105	258	534	602	671	1,261	1,495	1,362	1,298	763	787
Other assets	1	1	0	0	0	2	5	0	2	4	3	5	6
Total assets	122	104	105	258	534	602	671	1,261	1,495	1,362	1,298	763	787
Accounts payable	11	6	4	8	4	3	2	4	2	4	8	5	2
Accrued liabilities	8	5	5	5	5	6	7	19	10	19	18	16	12
Current contingent liabilities	7	0	2	7	10	5	5	6	3	40	3	0	0
Deferred revenue	-	-	-	-	-	-	-	3	2	29	11	0	1
Current operating lease liabilities	-	-	-	-	-	-	-	-	-	2	2	1	0
Current finance lease liabilities	-	-	-	-	-	-	-	-	-	7	0	0	0
Convertible Debt, Current	-	-	-	-	-	213	225	26	-	-	-	77	-
Total current liabilities	44	35	29	23	21	227	239	82	17	100	42	99	17
Total current liabilities	44	35	29	23	21	227	239	82	17	100	42	99	17
Convertible Debt, Noncurrent	-	-	-	-	-	-	-	610	639	442	321	-	-
Long-term deferred revenue	3	2	2	2	-	-	4	-	-	-	-	-	1
Long-term contingent liabilities	11	11	12	8	3	3	9	7	6	9	8	3	3
Deferred income taxes, net	-	-	-	-	-	-	-	-	33	65	59	31	32
Long-term operating lease liabilities	-	-	-	-	-	-	-	-	10	6	15	10	6
Other long-term liabilities	0	1	1	1	0	1	1	1	22	31	31	22	28
Total liabilities	105	78	55	234	230	231	252	700	728	653	476	165	86
Total liabilities	105	78	55	234	230	231	252	700	728	653	476	165	86
Common Stock, Value, Issued	0	0	0	0	0	0	0	0	0	0	0	0	0
Additional paid-in capital	733	752	718	681	701	770	798	791	367	318	373	148	199
Accumulated other comprehensive loss	-	-	3	5	5	3	2	-1	-0	-1	-1	-1	-1
Retained earnings	-682	-683	-671	-659	-402	-431	-401	-229	400	392	449	451	503
Total stockholders’ equity	-	26	50	26	304	341	400	561	767	710	821	597	701
Common Stock, Value, Issued	0	0	0	0	0	0	0	0	0	0	0	0	0
Additional paid-in capital	733	752	718	681	701	770	798	791	367	318	373	148	199
Accumulated other comprehensive loss	-	-	3	5	5	3	2	-1	-0	-1	-1	-1	-1
Retained earnings	-682	-683	-671	-659	-402	-431	-401	-229	400	392	449	451	503
Total stockholders’ equity	-	26	50	26	304	341	400	561	767	710	821	597	701
Total liabilities and stockholders’ equity	122	104	105	258	534	602	671	1,261	1,495	1,362	1,298	763	787
Total liabilities and stockholders’ equity	122	104	105	258	534	602	671	1,261	1,495	1,362	1,298	763	787